Data / Form D filings / Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc.: Form D filings
Millendo Therapeutics, Inc., a pharmaceuticals company in Ann Arbor, MI, filed 6 Form D notices with the SEC between 2012 and 2017. The latest, on December 28, 2017, reports $50 million sold of a $59.1 million offering to 14 investors.
Find out what Millendo Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 301 NORTH MAIN STREET, SUITE 100, Ann Arbor, MI, 48104
- Phone
- (734) 845-9000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1547547
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 28, 2017 | New notice | $59,109,960 | $50,043,201 | $9,066,759 | 14 | Dec 19, 2017 | sec.gov |
| Jan 4, 2016 | New notice | $70,702,987 | $47,697,172 | $23,005,815 | 21 | Dec 18, 2015 | sec.gov |
| Feb 26, 2013 | Amendment | $16,633,013 | $8,522,872 | $8,110,141 | 7 | Jul 25, 2012 | sec.gov |
| Sep 27, 2012 | Amendment | $16,633,013 | $3,506,411 | $13,126,602 | 6 | Jul 25, 2012 | sec.gov |
| Aug 3, 2012 | New notice | $16,633,013 | $1,506,411 | $15,126,602 | 4 | Jul 25, 2012 | sec.gov |
| Apr 23, 2012 | New notice | $500,000 | $250,000 | $250,000 | 1 | Apr 17, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Pharis Mohideen | Executive Officer | |
| James Hindman | Director | |
| Christopher Seiter | Executive Officer | |
| Thierry Abribat | Director | |
| James Topper | Director | |
| Randall Whitcomb | Director | |
| Julia Owens | Executive Officer, Director | |
| Carol Gallagher | Director | |
| Carole Neuchterlein | Director | |
| Jeffery Brinza | Executive Officer | |
| Mary Lynne Hedley | Director |
Other pharmaceuticals companies in Michigan that filed recently
- IMACS Working Capital Facility One LLC $200,000 · Sep 17, 2026
Every Form D from the week of Dec 25, 2017 · All recent filings in Michigan · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Millendo Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.